−395 KRW
−15.24 B KRW
267.31 M KRW
22.11 M
About KAINOS MEDICINE, INC.
Sector
Industry
CEO
Ki-Sub Lee
Website
Headquarters
Seongnam-si
Founded
2007
ISIN
KR7284620002
FIGI
BBG00JHQYHB5
Kainos Medicine, Inc. engages in the research and development of pharmaceutical products. It develops degenerative brain disease treatment, anti-viral, and anti-cancer drugs. The company was founded on June 15, 2007 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 284620 is 3,355 KRW — it has increased by 2.76% in the past 24 hours. Watch KAINOS MEDICINE, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KAINOS MEDICINE, INC. stocks are traded under the ticker 284620.
284620 stock has risen by 49.11% compared to the previous week, the month change is a −11.94% fall, over the last year KAINOS MEDICINE, INC. has showed a −20.31% decrease.
284620 reached its all-time high on Aug 5, 2020 with the price of 30,515 KRW, and its all-time low was 2,130 KRW and was reached on Dec 13, 2024. View more price dynamics on 284620 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
284620 stock is 19.06% volatile and has beta coefficient of 0.68. Track KAINOS MEDICINE, INC. stock price on the chart and check out the list of the most volatile stocks — is KAINOS MEDICINE, INC. there?
Today KAINOS MEDICINE, INC. has the market capitalization of 93.29 B, it has increased by 1.15% over the last week.
Yes, you can track KAINOS MEDICINE, INC. financials in yearly and quarterly reports right on TradingView.
284620 net income for the last quarter is −2.42 B KRW, while the quarter before that showed −3.02 B KRW of net income which accounts for 20.05% change. Track more KAINOS MEDICINE, INC. financial stats to get the full picture.
No, 284620 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 19.00 employees. See our rating of the largest employees — is KAINOS MEDICINE, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAINOS MEDICINE, INC. EBITDA is −10.73 B KRW, and current EBITDA margin is −5.81 K%. See more stats in KAINOS MEDICINE, INC. financial statements.
Like other stocks, 284620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAINOS MEDICINE, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAINOS MEDICINE, INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAINOS MEDICINE, INC. stock shows the sell signal. See more of KAINOS MEDICINE, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.